Jesus San Miguel, MD, PhD¹, Maria-Victoria Mateos, MD, PhD², Jatin J. Shah, MD³, Enrique M. Ocio, MD, PhD^4*, Paula Rodriguez-Otero, MD, PhD^5*, Donna Reece, MD⁶, Nikhil C. Munshi, MD⁷, David E. Avigan, MD⁸, Yang Ge, PhD^9*, Arun Balakumaran, MD, PhD, SM^9*, Patricia Marinello, PharmD^9*, Robert Z. Orlowski, MD, PhD³ and David S Siegel, MD, PhD¹⁰

¹Clínica Universidad de Navarra, Universidad de Navarra, Pamplona, Spain
²Hospital Universitario de Salamanca-IBSAL, Salamanca, Spain
³The University of Texas MD Anderson Cancer Center, Houston, TX
⁴University Hospital of Salamanca, Salamanca, Spain
⁵Clínica Universidad de Navarra, Pamplona, Spain
⁶Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
⁷Jerome Lipper Multiple Myeloma Center, Dana Farber Cancer Institute, Boston, MA
⁸Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
⁹Merck & Co., Inc., Kenilworth, NJ
¹⁰Hackensack University Medical Center, John Theurer Cancer Center, Hackensack, NJ

Ashraf Z. Badros, MD, Mehmet H. Kocoglu, MD, Ning Ma, NP^*, Aaron P. Rapoport, MD, Emily Lederer, RN^*, Sunita Philip, MBBS^*, Patricia Lesho^*, Cameron Dell^*, Nancy M. Hardy, MD, Jean Yared, MD^*, Olga Goloubeva, PhD^* and Zeba Singh, MD

University of Maryland, Baltimore, MD

Torben Plesner, MD¹, Hendrik-Tobias Arkenau^2*, Peter Gimsing^3*, Jakub Krejcik^1*, Charlotte Lemech^2*, Monique C. Minnema⁴, Ulrik Lassen^3*, Jacob P. Laubach, MD⁵, Antonio Palumbo⁶, Steen Lisby⁷, Linda Basse^7*, Jianping Wang^8*, A Kate Sasser^8*, Mary E Guckert^8*, Howard Yeh⁹, Tahamtan Ahmadi^8*, Henk M. Lokhorst¹⁰ and Paul G. Richardson¹¹

¹Vejle Hospital, Vejle, Denmark
²Sarah Cannon Research Institute, London, United Kingdom
³Department of Haematology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
⁴Department of Hematology, UMC Utrecht Cancer Center, Utrecht, Netherlands
⁵Dana-Farber Cancer Institute, Boston, MA
⁶University of Torino, Torino, Italy
⁷Genmab A/S, Copenhagen, Denmark
⁸Janssen Research & Development, LLC, Spring House, PA
⁹Janssen Research & Development, LLC, Raritan, NJ
¹⁰Hematology, UMC Utrecht, Utrecht, Netherlands
¹¹The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

Ajai Chari, MD¹, Sagar Lonial, MD^2,3, Attaya Suvannasankha⁴, Joseph W. Fay⁵, Bertrand Arnulf^6*, Jainulabdeen J. Ifthikharuddin⁷, Xiang Qin^8*, Tara Masterson^8*, Kerri Nottage^9*, Jordan M Schecter^9*, Tahamtan Ahmadi^8*, Brendan Weiss^10*, Amrita Krishnan¹¹ and Suzanne Lentzsch¹²

¹Tisch Cancer Institute, Mount Sinai School of Medicine, New York, NY
²Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA
³Winship Cancer Institute of Emory University, Department of Hematology and Medical Oncology, Atlanta, GA
⁴Indiana University School of Medicine and Simon Cancer Center, Richard L. Roudebush VAMC, Indianapolis, IN
⁵Baylor Institute for Immunology Research, Dallas, TX
⁶Hôpital Saint Louis, Paris, France
⁷James P. Wilmot Cancer Center, University of Rochester Strong Memorial Hospital, Rochester, NY
⁸Janssen Research & Development, LLC, Spring House, PA
⁹Janssen Research & Development, LLC, Raritan, NJ
¹⁰Abramson Cancer Center and Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
¹¹City of Hope, Duarte, CA
¹²Columbia University Medical Center, New York, NY

Thomas Martin, MD¹, Joshua Richter, MD², Ravi Vij, MD³, Craig Cole, MD^4*, Djordje Atanackovic, MD⁵, Jeffrey Zonder, MD⁶, Jonathan L. Kaufman, MD⁷, William Bensinger, MD^8*, Meletios A. Dimopoulos⁹, Jesús San Miguel, MD PhD^10*, Todd Zimmerman, MD¹¹, Nikoletta Lendvai, MD PhD¹², Parameswaran Hari, MD, MRCP, MS¹³, Enrique M. Ocio, MD, PhD^14*, Cristina Gasparetto, MD¹⁵, Shaji Kumar, MD¹⁶, Karl Hsu, MD¹⁷, Eric Charpentier, MSc^17*, Stephen A. Strickland, MD¹⁸ and Joseph Mikhael, MD^19*

¹University of California, San Francisco, CA
²Hackensack University Medical Center, Hackensack, NJ
³Washington University, St. Louis, MO
⁴Internal Medicine - Hematology and Oncolgy, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI
⁵Huntsman Cancer Institute, Salt Lake City, UT
⁶Karmanos Cancer Institute, Detroit, MI
⁷Winship Cancer Institute of Emory University, Atlanta, GA
⁸Fred Hutchinson Cancer Research Center, Seattle, WA
⁹National and Kapodistrian University of Athens, Athens, Greece
¹⁰University of Navarra, Pamplona, Spain
¹¹University of Chicago Medical Center, Chicago, IL
¹²Memorial Sloan-Kettering Cancer Center, New York, NY
¹³Medical College of Wisconsin, Milwaukee, WI
¹⁴University Hospital of Salamanca, Salamanca, Spain
¹⁵Duke University Medical Center, Durham, NC
¹⁶Division of Hematology, Mayo Clinic, Rochester, MN
¹⁷Sanofi Oncology, Cambridge, MA
¹⁸Vanderbilt-Ingram Cancer Center, Nashville, TN
¹⁹Mayo Clinic, Scottsdale, AZ

Antonio Palumbo, MD¹, Massimo Offidani, MD², Brigitte Pégourie^3*, Javier De La Rubia^4*, Laurent Garderet, MD⁵, Kamel Laribi^6*, Alberto Bosi, MD⁷, Roberto Marasca, MD⁸, Jacob P. Laubach, MD⁹, Ann Mohrbacher, MD¹⁰, Angelo Michele Carella, MD¹¹, Anil K. Singhal^12*, Mark Lynch^13*, Ying-Ming Jou^14* and Andrzej Jakubowiak, MD, PhD¹⁵

¹Azienda Ospedaliero Universitaria San Giovanni Battista di Torino - Ospedale Molinette, Torino, Italy
²Azienda Ospedaliero Universitaria Ospedali Riuniti di Ancona, Ancona, Italy
³CHU de Grenoble - Hôpital Albert Michallon, Grenoble, France
⁴H.U.P. La Fe, Valencia, Spain
⁵Hôpital Saint Antoine, Paris, France
⁶Centre Hospitalier, Le Mans, France
⁷Azienda Ospedaliero Universitaria Careggi, Florence, Italy
⁸Azienda Ospedaliera Universitaria - Policlinico di Modena, Modena, Italy
⁹Dana-Farber Cancer Institute, Boston, MA
¹⁰University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA
¹¹IRCCS San Martino-IST, Genova, Italy
¹²AbbVie Biotherapeutics Inc. (ABR), Redwood City, CA
¹³Bristol-Myers Squibb, Wallingford, CT
¹⁴Bristol-Myers Squibb, Hopewell, NJ
¹⁵University of Chicago Medical Center, Chicago, IL